title: Presentation and outcome of paediatric membranous non-proliferative lupus nephritis.
abstract: BACKGROUND
  Studies of paediatric patients with membranous lupus nephritis (MLN) have yielded variable results, mostly due to the inclusion of mixed, i.e. proliferative nephritis. The aim of this study was to describe clinical and laboratory findings at the diagnosis of paediatric non-proliferative MLN, report the outcome and identify predictors of remission.
  
  
  METHODS
  A single-center cohort study of consecutive children diagnosed with non-proliferative MLN was performed. Clinical and laboratory measures and treatment regimens were obtained in prospective standardized assessments. Renal outcome was measured by renal parameters and steroid requirement. Predictors for remission and time to remission were determined.
  
  
  RESULTS
  A total of 30 children were identified with a median follow-up time 4.1 years. Of 21 patients followed for more than 2 years, 19 (90 %) achieved clinical remission, and 16 (76 %) achieved a state of maintained clinical remission on low-dose prednisone. Three patients developed proliferative nephritis on subsequent renal biopsy. Lower albumin at the time of biopsy was correlated with a lower rate of remission and longer time to remission.
  
  
  CONCLUSIONS
  Among our paediatric patient cohort the outcome of non-proliferative MLN in systemic lupus erythematosus was good. The majority of patients did not require aggressive immunosuppressive treatment to reach a stable disease state on low-dose steroid treatment.
authors: Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
authors: Boris
authors: B
authors: Hugle
authors: Earl D
authors: ED
authors: Silverman
authors: Pascal N
authors: PN
authors: Tyrrell
authors: Elizabeth A
authors: EA
authors: Harvey
authors: Diane
authors: D
authors: Hébert
authors: Susanne M
authors: SM
authors: Benseler
mesh_terms: D000293:Adolescent; D002648:Child; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008181:Lupus Nephritis / Q000503:physiopathology* / Q000628:therapy*; D008297:Male; D012074:Remission Induction; D016896:Treatment Outcome